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Abstract
Background: Diagnostic tools for lymphatic filariasis (LF) elimination programs are useful in mapping the distribution
of the disease, delineating areas where mass drug administrations (MDA) are required, and determining when to stop
MDA. The prevalence and burden of LF have been drastically reduced following mass treatments, and the evaluation
of the performance of circulating filarial antigen (CFA)-based assays was acknowledged to be of high interest in areas
with low residual LF endemicity rates after multiple rounds of MDA. The objective of this study was therefore to
evaluate the immunochromatographic test (ICT) sensitivity in low endemicity settings and, specifically, in individuals
with low intensity of lymphatic filariasis infection.
Methods: To perform this study, calibrated thick blood smears, ICT and Og4C3 enzyme-linked immunosorbent assay
(ELISA) were carried out by night to identify Wuchereria bancrofti microfilarial and circulating filarial antigen carriers. A
threshold determination assay regarding ICT and ELISA was performed using serial plasma dilutions from individuals
with positive microfilarial counts.
Results: All individuals harbouring microfilariae (positive blood films) were detected by ICT and ELISA, but among
individuals positive for ELISA, only 35.7 % of them were detected using ICT (Chi square: 4.57; p-value = 0.03), indicating
a moderate agreement between both tests (kappa statistics = 0.49). Threshold determination analyses showed that
ELISA was still positive at the last plasma dilution with negative ICT result.
Conclusions: These findings suggest a loss of sensitivity for ICT in low endemicity settings, especially in people
exhibiting low levels of circulating filarial antigen, raising serious concern regarding the monitoring and evaluation
procedures in the framework of LF elimination program.
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Background
Lymphatic filariasis (LF), better known as elephantiasis,
is a mosquito-borne parasitic disease caused by the
nematode parasites Wuchereria bancrofti, Brugia malayi
and Brugia timori. This filarial disease is one of the most
important public health problems facing many countries
in the tropics. It is estimated that 120 million people are
infected, and about 40 million disfigured and incapaci-
tated by the disease [1]. In addition to physical disability,
LF is also responsible of an important socio-economic
burden, with for instance negative impact on marriage-
ability and conjugal life of hydrocele individuals [2]. In
2000, the Global Programme to Eliminate Lymphatic
Filariasis (GPELF) was launched by the World Health
Organization (WHO) to help eliminating the disease as
a public health problem. LF is now among the neglected
tropical diseases targeted for elimination by 2020 [3]. To
achieve this ambitious goal, the strategy developed by
the GPELF is to stop the transmission through large-scale
annual treatment (ivermectin or diethylcarbamazine in
combination with albendazole) of all eligible individuals
living in endemic areas, and alleviate the suffering caused
by LF through morbidity management and disability pre-
vention activities [1]. Four programmatic steps - mapping,
mass drug administration (MDA), surveillance and verifi-
cation - were recommended to achieve transmission inter-
ruption. In Cameroon, apart from a systematic review
reporting quite old LF data [4], very few data were avail-
able from limited number of recent field surveys [5, 6].
According to these epidemiological data, either old or
recent, the prevalence of LF infection was less than 25 %
over the country. In order to follow the GPELF guidelines,
a nationwide map of LF was conducted to accurately
delineate areas where MDA is required [7]. During the
mapping exercise, WHO recommends to classify each
surveyed area as endemic or non-endemic, and identify
sentinel and spot check sites where baseline data should
be collected to provide metrics necessary for the evalu-
ation of the success of the program [8]. A number of tools
are currently available for the diagnosis of W. bancrofti
infection but blood films and ICT were chosen to monitor
and evaluate the different programmatic steps necessary
to achieve LF elimination [9]. The choice of these diagnos-
tic tools depends upon their sensitivity and specificity, as
well as their feasibility in terms of field implementation,
technical skills required and cost. Although blood film can
overestimate MDA success because of loss of sensitivity
when the prevalence and intensity of infection are low, it
can be underestimated by ICT since residual antigen levels
may persist for up to three years post-treatment in
microfilaria-negative individuals [10]. It was shown that
ICT card test is very easy to perform, with a high level of
sensitivity for the detection of filarial antigen as with
ELISA, especially in the laboratory conditions [11, 12].
However, recent evidences indicate that the sensitivity of
ICT might be highly variable, depending on age, sex, pres-
ence or absence of living adult worms, as well as microfi-
larial density [13]. Indeed, a positive trend was found
between microfilarial density (measure by blood smears)
and circulating filarial antigen (CFA), measured either by
ICT or ELISA, as well as with the number of adult worms
assessed by ultrasound [13, 14]. The objective of the
present study was to evaluate, in the field conditions, the
ICT sensitivity in low endemicity settings, especially in
individuals exhibiting low intensity of LF infection, with
the ultimate goal to check whether ICT might remain
suitable to evaluate the success of LF elimination program.
Methods
Study design and patients
The present survey was carried out in two steps following
WHO recommendations, to (i) determine where active LF
transmission was occurring, and (ii) provide metrics for
further evaluation of the success of MDA [8]. To this end,
four health districts (Kar-Hay, Kousseri, Pette and Yagoua)
located in the Far North Region of Cameroon (Fig. 1) were
selected as part of the countrywide mapping operations.
The study area delimited by these four health districts was
known as an historical focus of LF [4], with prevalence
ranging from 0.4 to 22.1 % [15–18], but where no mass
antifilarial intervention was ever performed before the
outset of our survey. The overall population of these four
health districts was 490 470 individuals at the outset of
the study. WHO recommends a sentinel site of 300–500
individuals for MDA impact assessments in an implemen-
tation unit of 1 000 000 individuals [8]. In each of these
health districts (implementation units for health interven-
tions in Cameroon), couples of communities (1–2) with
the highest disease or parasite prevalence were chosen as
sentinel sites, with the assumption that they were likely to
require the longest period of time for interruption of
transmission [8]. Fig. 2 displays a chart indicating the
different steps of the study including selection and flow of
participants as well as sample collection and laboratory
processing. In each community, ICT tests were performed
to update the prevalence of LF in this area, and night
blood smears realized to collect baseline parasitological
data to monitor the success of the LF control program [8].
Individuals eligible for this survey were either male or
female, aged 5 years old and over. They were invited at a
central place in each community (usually at the chief
palace) and all volunteers undergo clinical examination
for LF clinical signs, and blood sample collection for
prevalence and intensity of the infection. The entire pro-
cedures were performed by night (from 10 PM to 2 AM
the next day) to take into account the nocturnal period-
icity of W. bancrofti [19].
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Clinical examination
Before undergoing blood drawing and subsequent CFA
(ICT and ELISA) and microfilarial (CTBS) detection, a clin-
ical examination was performed to seek for the most strik-
ing LF clinical signs. Lower limbs and men scrotum were
inspected for elephantiasis and hydrocele, respectively.
Blood drawing and laboratory processing for circulating
filarial antigen (CFA) detection
Five millilitre of venous blood was collected, from each
eligible volunteer, in EDTA tube. After centrifugation at
6000 rpm for 5 min, plasma was collected and stored at
−20 °C for further serological analyses. CFA detection
was performed in the Centre for Research on Filariasis
and other Tropical Diseases (CRFilMT) laboratory, using
the classical recommended mapping tool (ICT test) to
appreciate the prevalence of the infection [8], and the
Og4C3 ELISA assay as a confirmation test.
ICT is a rapid card test manufactured by BinaxNow
(Scarborough, USA) for the detection of 200 kDaW.
bancrofti CFA [20]. A volume of 100 μL of each individ-
ual plasma sample was added to the sample pad of the
card according to the manufacturer protocol. This pad
contains a gold-labelled polyclonal anti-filarial antibody
that binds to filarial antigen from the plasma. Once the
card is closed, the pad comes into contact with a nitro-
cellulose strip. The antibody-antigen complex then
moves along the strip and is trapped by an immobilized
anti-filarial monoclonal antibody (AD12.1) present in
the strip’s coating. At 10 min, pink control (C) and test
(T) lines are visible for all valid positive tests, whereas
only the control pink line appears for antigen-negative
individuals.
Fig. 1 Map showing health districts surveyed in the Far North Region of Cameroon. The grey zones indicate the health districts surveyed
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The Og4C3 ELISA test kit, specific for W. Bancrofti
CFA, was used following the manufacturer (TropBio Pty
ldt, Queensland, Australia) recommendations. Briefly,
100 μL of each individual plasma sample, mixed with
300 μL EDTA solution, was boiled at 100 °C for 5 min
to release the heat stable CFA in positive specimens.
After centrifugation (10,000 rpm for 5 min), 50 μL of
supernatant was added, in duplicate, in microtitre plates
previously coated with a monoclonal anti-filarial anti-
body (Og4C3). Serial positive controls from seven stand-
ard antigens with known concentrations were added in
duplicate in microplate wells, and a negative control also
added in duplicate. After overnight incubation, micro-
plates were washed using a wash buffer (provided by the
manufacturer); then, 50 μL of rabbit anti-CFA antibody
was added in each microplate well, and the latter incu-
bated for one hour at room temperature. Microplates
were then washed again and 50 μL of anti-rabbit horse-
radish-peroxidase-conjugate added in each well. Finally,
microplates were developed by addition of a substrate,
and examined on HumaReader HS reader at 405 and
492 nm.
Calibrated thick blood smears (CTBS) for baseline data
collection
Calibrated thick blood smears (CTBS) were performed,
following standard protocol developed by the CRFilMT,
to assess the intensity of LF infection. Briefly, 50 μL of
blood sample was collected from finger-prick, spread on
a slide, water de-haemoglobinized and stained with Giemsa.
These preparations were examined under a light micro-
scope (magnification x100 or x400). W. bancrofti microfil-
ariae were identified and counted, and the results expressed
as microfilariae (mf) per millilitre of blood (mf/mL) [21].
Threshold determination between ICT and ELISA
Plasma samples with positive W. bancrofti microfilarial
count were tested by ICT and ELISA assays to assess the
threshold determination regarding CFA plasma level.
Serial plasma dilutions ranging from 1/2 to 1/128 were
performed using physiological water (0.9 % NaCl solu-
tion) and tested by ICT card. For each sample, the last
plasma dilution which yielded negative result to ICT was
tested by ELISA to compare threshold determination of
these two tests.
Data analysis
CFA (estimated with ICT and ELISA) and microfilarial
(estimated using CTBS) prevalences’ were expressed as
the percentage of infected individuals among the total
number of individuals examined; the intensity of infection
was calculated when the microfilarial count was available
as arithmetic means. Sampling fluctuations were esti-
mated either by the 95 % confidence interval (CI) for prev-
alences - calculated using the Wilson procedure without a
correction for continuity [22] - or by the standard devi-
ation (sd) for means. Sensitivity of ICT assays was esti-
mated using ELISA as the reference test. The sensitivity
was determined as the percentage of subjects with a posi-
tive ICT test among those positive for ELISA; in addition,
a Kappa statistics was performed to estimate the strength
of agreement between ICT and ELISA assays. The hier-
archical weights for agreement associated with kappa
statistics was ranged as follows: k < 0.00 to indicate no
agreement, k = 0.00–0.20 to indicate poor agreement,
k = 0.21–0.40 to indicate fair agreement, k = 0.41–0.60
to indicate moderate agreement, k = 0.61–0.80 to
indicate substantial agreement, and k = 0.81–1.00 to
indicate almost perfect agreement [23]. All statistical
analyses were performed online using VassarStats
computational website [24], non-overlapping 95 % CI
or p-values less than 5 % being considered as statisti-
cally significant.
Ethical statement
The Cameroon National Ethics Committee for Human
Research (CNERSH), which is in charge to approve any
research involving human subject in Cameroon, is under
the authority of the Ministry of Public Health. This study
was conducted as part of the action plan of the national
program to eliminate lymphatic filariasis in Cameroon, in
accordance to the ethical principle for medical research
involving human subjects as stated in the Declaration of
Fig. 2 Flow chart detailing the study design and the flow of
participants. * All the procedures were performed by night, from
10 PM to 2 AM the next day, on the same individuals. CTBS: calibrated
thick blood smear; mf: microfilariae; ICT: immunochromatographic test;
ELISA: enzyme-linked immunosorbent assay; LF: lymphatic filariasis;
CFA: circulating filarial antigen
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Helsinki. The survey was approved by, and undertaken
under the authority of, the Ministry of Public Health of
Cameroon. After approval of the local administrative and
traditional authorities, the objectives and schedule of the
study were first explained to community leaders and then
to all eligible individuals. The latter had the opportunity
to ask questions to have full information about their
participation in the survey before granting approval. Be-
cause of low literacy rate in some areas and the logistics
constraints related to the substantial number of individ-
uals to be sampled (this survey was part of the mapping
exercise at the national level), a written agreement was
not requested. Verbal agreements were recommended by
the Ministry of Public Health and obtained from those
who agreed to participate, under the discretion of commu-
nity leaders. Even after the agreement of minors, the
approval of their parents or legal guardians was necessary
before any procedure. Each team leader was responsible
to record agreements and attribute individual code to each
participant for anonymous data analysis. At the end of all
procedures and examinations, all individuals in each
health district found endemic for LF received an anti-
filarial treatment (single dose of ivermectin at 150 μg/kg
of bodyweight, in combination with albendazole 400 mg)
as part of the mass treatment administrated in the frame-
work of the LF elimination program.
Results
Prevalence and intensity of LF
Table 1 provides details of the prevalence and intensity of
LF infection, using ICT, ELISA and CTBS. In the four
health districts included in the present survey, 404 individ-
uals agreed to participate and provided samples for LF
diagnosis. All these 404 individuals were tested for ICT,
ELISA and CTBS. CFA was detected in 11 (2.7 %; 95 %
CI: 1.5–4.8) enrolees using ICT and in 28 (6.9 %; 95 %
CI: 4.8–9.8) individuals using ELISA, the difference
being significant (Chi square: 7.79; p-value = 0.0053).
CTBS revealed that 7 (1.7 %; 95 % CI: 0.8–3.5) of these
404 individuals harboured mf, with an intensity of
infection of 7.49 mf/mL (sd: 70.77).
Agreement between diagnostic tests and threshold
determination of LF CFA
All individuals with mf were identified using ICT and
ELISA, but among individuals positive for ELISA,
only 10 (35 %) were detected using ICT (Chi square:
4.57; p-value = 0.03), the value of the kappa statistics
(k = 0.49) indicating a moderate agreement between
ELISA and ICT [see Additional file 1: Dataset S1].
Threshold determination analyses showed that ICT
was positive at some dilution factors for different
plasma samples, but ELISA was still positive at the
last plasma dilution for which ICT yielded a negative
result.
Relationship between LF macroscopic lesions and CFA
Among the 404 individuals examined, none presented
with elephantiasis, whereas 21 (5.2 %; 95 % CI: 3.4–7.8)
were suffering from hydrocele (8 in Yagoua [5.6 %; 95 %
CI: 2.8–10.6], 12 in Kar-Hay [9.2 %; 95 % CI: 5.3–15.3]
and 1 in Pette [1.1 %; 95 % CI: 0.2–6.2]). W. bancrofti
circulating antigen from 20 of these individuals suffering
from hydrocele were identified by ELISA whereas only
two of them were detected using ICT [see Additional file
1: Dataset S1].
Discussion
Diagnostic tools are useful for (1) mapping the distribu-
tion of LF to delineate areas where MDA are required, (2)
assessing the impact of MDA to determine when they can
be stopped after transmission has been interrupted, and
(3) ensuring strong surveillance procedures post–MDA to
monitor possible resurgence [8, 12]. Although some of
these tools are difficult to implement in field conditions,
others lack sensitivity, especially when the intensity of
infection is low. The present study showed low level of LF
infection in the study area. A moderate agreement (kappa
statistics = 0.49) was found between ICT and ELISA, the
threshold determination analyses showing that ELISA was
still positive at the last plasma dilution with negative ICT
result.
Table 1 Prevalence and intensity of LF infection in four health districts of the Far North Region of Cameroon
Implementation unit Number examined % prevalence of ICT
(95 % CI)
% prevalence of ELISA
(95 % CI)
% prevalence of CTBS
(95 % CI)
Mean mf counta (sd)
Yagoua 144 6.3 (3.3–11.5) 9.7 (5.9–15.7) 4.2 (1.9–8.8) 19.72 (116.86)
Kar-Hay 131 1.5 (0.4–5.4) 9.9 (5.9–16.2) 0.8 (0.1–4.2) 1.37 (15.73)
Pette 87 0.0 (0.0–4.2) 1.1 (0.2–6.2) 0.0 (0.0–4.2) 0.00 (0.00)
Kousseri 42 0.0 (0.0–8.4) 0.0 (0.0–8.4) 0.0 (0.0–8.4) 0.00 (0.00)
Overall 404 2.7 (1.5–4.8) 6.9 (4.8–9.8) 1.7 (0.8–3.5) 7.48 (70.77)
amf count is expressed as the number of mf per mL of blood (mf/mL)
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ICT has been chosen by the GPELF since more than
10 years to serve as the reference test in the framework
of LF global elimination, and has almost always been
presented to be as sensitive as ELISA [12, 20]. However,
we surprisingly found in the present study that ELISA
was significantly more sensitive than ICT, with a moder-
ate - at the edge of a fair - agreement for the detection
of LF circulating antigen. It was previously demonstrated
that amicrofilaremic adult worm carriers or persons with
ultra-low mf density could be at increased risk for false-
negative ICT results [11, 25], the sensitivity of Og4C3
ELISA being reduced at about 75 % in individuals har-
bouring ≤50mf/mL [14]. Indeed, the mean microfilarial
density found in the present study was equal to 7.49 mf/
mL (sd: 70.77), and serial dilutions of mf positive sam-
ples confirm the ICT loss of sensitivity when the CFA
concentration was diluted and consequently drops down
as observed elsewhere [20, 25]. A high correlation was
previously reported between mf densities and ELISA ti-
tres, ICT results as well as the numbers of adult worms,
the degree of relationship being improved with increas-
ing mf densities [13]. This can suggest that the mf dens-
ity can be used as a proxy to estimate the adult worm
carriage, and therefore the CFA level in the plasma.
Given the low sample size of mf infected individuals in
our study (only 7 found), we didn’t attempt to correlate
the mf densities to the ICT outcome or ELISA titres.
One must however pointed out that ELISA was always
positive when ICT yielded a negative result.
The loss of ICT sensitivity in people harbouring low
mf densities or low CFA level might be a limiting factor
for the use of ICT in low prevalence settings where the
likelihood to find individuals with low intensity of infec-
tion is high. In addition, since repeated treatments lower
individual mf density, ICT might not be appropriate for
the monitoring of the impact of MDA on the endemicity
or transmission of the infection. These results corrobor-
ate those obtained during the validation of a newly
developed test (Alere Filariasis test strip) in Liberia
where mass treatments were distributed just six months
before the field study [26]. Indeed, the Alere Filariasis
test strip was significantly more sensitive than the ICT
card test, by detecting 26.5 % more individuals with
CFA. Also, in a prevalence study from a low endemic
area in Bangladesh, the sensitivity of ELISA was shown
to be significantly higher than that of ICT after five
rounds of MDA [25]. More importantly, ICT has mis-
classified this area as no longer requiring treatments and
ELISA therefore proposed for post-MDA surveillance.
However, Og4C3 ELISA can also experience loss of sen-
sitivity (even at a reduced magnitude as compared to
ICT), and some limitations such as the necessity of
laboratory infrastructure for performance and interpret-
ation of the results [20]. Therefore, the development and
validation of improved and practical methods for assessing
filariasis transmission as well as post-MDA surveillance
improved protocols for early detection of persistent or re-
surgent LF transmission are still needed [9].
Limitations of the study and possible bias
The present study was part of the Cameroon wide LF map-
ping exercise, following the WHO recommendations. As
such, it was not designed to compare ICT and ELISA
assays. Although sample size was sufficient to draw solid
enough conclusion regarding antigenaemia detection using
ICT and ELISA (the power of statistical tests were ~80 %),
we didn’t attempt any inferential statistics for threshold
determination analysis. Indeed, as a consequence of the low
prevalence and intensity of LF in the study area, a reduced
number (seven) of subjects was mf positive and their sera
available for the threshold determination analysis. However,
the trend observed was very interesting and might deserve
further investigations. Also, at the contrary of ELISA, ICT
was not designed to be tested on diluted samples since this
could affect the performance of the test in unknown ways.
In the present study, these dilutions were performed to
mimic a reduced concentration of filarial antigen in the
plasma, and the ICT test remained positive at some dilu-
tion factors. The test line was clearly visible at 10 min for
each plasma dilution positive for ICT, whereas negative
dilutions displayed no test line, even beyond the 10 min
recommended by the manufacturer. We hypothesised that
such dilution might reduce the affinity of the antigen-
antibody complex and therefore the sensitivity of the test.
Similar trends were observed during the analytical compari-
son of the sensitivity of ICT and its next generation
homologue (Alere Filariasis test strip). Indeed, parallel test-
ing performed from serial dilutions of a filarial antigen
(DATH) [26, 27] have shown that the ICT card test was
weakly positive with antigen diluted 1/4, higher dilutions
being clearly negative, and the minimum concentration
detected by the test strip was two to four fold lower than
the minimum detected using ICT card test [26].
Conclusion
The elimination of LF is now on top of agenda of control
programs and stakeholders; our findings suggest that care
should be taken when using ICT card test for monitoring
and evaluation procedures, and development of highly
sensitive tests are of interest. Indeed, very sensitive poly-
merase chain reaction (PCR) assay have been developed,
some being able to detect an amount of DNA equivalent
to half mf per ml of blood [28]. However, such assays are
highly labour-intensive and expensive for routine use in
endemic areas [20]. We welcome the next generation of
ICT card test, the Alere Filariasis test strip, which has
been developed and tested both in laboratory and in the
field condition in Liberia. Although the newly developed
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test strip appears to be more sensitive, affordable and
most suitable for routine field assays, it is based on the
same principle as with the ICT card test and reagents used
are the same [25]. Therefore, more field testing might be
of importance to validate this new test, especially in set-
tings with low prevalence and intensity of infection where
loss of sensitivity with ICT card tests has been observed.
This is more than ever important since this test will likely
replace the ICT card test and used to assess the success of
MDA on the transmission of LF, and therefore guide the
decision to stop MDA.
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